-
Biotech Giant WANTAI BioPharm Reports 90% Decline in Net Profit, AstraZeneca's Revenue Surges by 19%...
This article delves into the financial performance of these two industry players during the first quarter of 2024.
2024-04-26 15:23 -
Roche's Vabysmo Shines in Q1 2024 as Tumor Pipeline Gets a Boost
This article examines Roche's Q1 2024 performance, highlights the success of Vabysmo, and explores the company's plans for future drug developments. ...
2024-04-26 15:20 -
BenevolentAI, an AI Pharmaceutical Company, Announces Further Workforce Reduction and Closure of US ...
BenevolentAI, a publicly listed AI pharmaceutical company based in the UK, has recently made the decision to implement another round of layoffs, reduc...
2024-04-25 15:01 -
Novartis Reports Soaring Q1 Performance with the Emergence of Billion-Dollar Blockbusters
Novartis, a leading pharmaceutical company, has recently announced its impressive financial results for the first quarter of 2024.
2024-04-25 15:00 -
Breakthrough Collaboration: Ipsen and Skyhawk Therapeutics Join Forces in RNA-Targeted Small Molecul...
In a groundbreaking partnership, Ipsen and Skyhawk Therapeutics have recently announced a global exclusive collaboration agreement to jointly develop ...
2024-04-24 15:50 -
Sanofi Pays $100 Million in Settlement to Resolve Zantac Cancer Lawsuits
In a recent development, pharmaceutical giant Sanofi has agreed to pay a staggering $100 million to settle a portion of the lawsuits related to its po...
2024-04-24 15:47 -
Ipsen Makes Another Major Investment of Up to $1.8 Billion in Rare Disease Pipeline
Ipsen's commitment extends to granting exclusive global rights to two candidate products, with potential milestone payments reaching as high as $1.8 b...
2024-04-23 16:34 -
Renowned Scientist Najat Khan Departs Johnson & Johnson to Join TechBio
In a surprising move, renowned scientist Najat Khan has announced her departure from Johnson & Johnson to join the ranks of TechBio, an AI-driven phar...
2024-04-23 16:33 -
The Impending MASH Outbreak: A Promising Wave of New Drugs on the Horizon
This article explores the factors contributing to the imminent MASH outbreak and highlights the emergence of promising new drugs that hold the potenti...
2024-04-23 16:30 -
Exceed $1 Billion: Boehringer Ingelheim and Ochre Bio Collaborate on Liver Disease Regenerative Ther...
In a groundbreaking collaboration, pharmaceutical giant Boehringer Ingelheim and biotech company Ochre Bio have joined forces to develop innovative re...
2024-04-23 16:30
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
